drugset / Trial / NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
RandomizedSequentialOpen-labelTreatment
Summary
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer.
Timeline
- Start
- 2025-10-01
- Primary completion
- 2029-01-18
- Completion
- 2029-01-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD0516 | Unknown | — | Intravenous |
| Subject | AZD9574 | Small molecule | — | Oral |